(Q36167873)

12 August 2017

1 reference

title

Current drug therapy for Parkinson's disease. A review (English)

1 reference

12 August 2017

1 reference

R. J. Coleman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1596594

12 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1596594

12 October 2022

publication date

1 March 1992

1 reference

12 August 2017

1 reference

12 August 2017

2

1 reference

12 August 2017

2

1 reference

12 August 2017

112-124

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199202020-00005

12 August 2017

0 references

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Long-term study of pergolide in Parkinson's disease

1 reference

12 December 2020

Dopamine: Release from the Brain in vivo by Amantadine

1 reference

12 December 2020

Long-term experience with pergolide therapy of advanced parkinsonism

1 reference

12 December 2020

Dopamine (3-hydroxytyramine) and brain function

1 reference

12 December 2020

Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Amantadine in the Treatment of Parkinson's Disease

1 reference

12 December 2020

A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance

1 reference

12 December 2020

Dopamine D2 receptor density remains constant in treated Parkinson's disease.

1 reference

12 December 2020

EFFECTS OF TRIHEXYPHENIDYL HYDROCHLORIDE (ARTANE) ON PARKINSON'S DISEASE.

1 reference

12 December 2020

Control of on/off phenomenon by continuous intravenous infusion of levodopa

1 reference

12 December 2020

Clozapine. A novel antipsychotic agent

1 reference

12 December 2020

Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease

1 reference

12 December 2020

Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis.

1 reference

12 December 2020

Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier

1 reference

12 December 2020

Lisuride in parkinsonism

1 reference

12 December 2020

Apomorphine in Parkinson's disease

1 reference

12 December 2020

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

12 December 2020

Cholinergic-anticholinergic antagonism in parkinsonism.

1 reference

12 December 2020

Young onset Parkinson's disease

1 reference

12 December 2020

Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study

1 reference

12 December 2020

Present views on the mode of action of acetylcholine in the central nervous system

1 reference

12 December 2020

The promise and limitations of controlled-release oral levodopa administration

1 reference

12 December 2020

Bromocriptine and lisuride in Parkinson disease

1 reference

12 December 2020

Domperidone and Parkinson's disease.

1 reference

12 December 2020

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

1 reference

12 December 2020

A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease

1 reference

12 December 2020

DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism

1 reference

12 December 2020

Selegiline in the early and late phases of Parkinson's disease.

1 reference

12 December 2020

Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide

1 reference

12 December 2020

Livedo Reticularis in Patients With Parkinsonism Receiving Amantadine

1 reference

12 December 2020

Further Studies on the Mode of Action of Amantadine

1 reference

12 December 2020

Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.

1 reference

12 December 2020

A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease

1 reference

12 December 2020

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

12 December 2020

The comparative value of amantadine and levodopa

1 reference

12 December 2020

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

1 reference

12 December 2020

Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease

1 reference

12 December 2020

Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study

1 reference

12 December 2020

Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease

1 reference

12 December 2020

Nonaminergic striatal neurons convert exogenous l-dopa to dopamine in parkinsonism

1 reference

12 December 2020

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

1 reference

12 December 2020

Bromocriptine and dopamine receptor stimulation

1 reference

12 December 2020

Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease.

1 reference

12 December 2020

The hydrodynamically balanced system: a novel principle of controlled drug release

1 reference

12 December 2020

Pharmacokinetics of Levodopa

1 reference

12 December 2020

Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease

1 reference

12 December 2020

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

1 reference

12 December 2020

Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations.

1 reference

12 December 2020

The impact of treatment with levodopa on Parkinson's disease.

1 reference

12 December 2020

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

1 reference

12 December 2020

Enhanced response to low doses of levodopa after withdrawal from chronic treatment

1 reference

12 December 2020

Anticholinergic and membrane activities of amantadine in neuromuscular transmission

1 reference

12 December 2020

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease

1 reference

12 December 2020

Subcutaneous apomorphine in the treatment of Parkinson's disease

1 reference

12 December 2020

Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease

1 reference

12 December 2020

[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results]

1 reference

12 December 2020

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

1 reference

12 December 2020

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

12 December 2020

Controlled-release levodopa/carbidopa. II. Sinemet CR4 treatment of response fluctuations in Parkinson's disease

1 reference

12 December 2020

Levodopa in Parkinsonism: the Effects of Withdrawal of Anticholinergic Drugs

1 reference

12 December 2020

Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic

1 reference

12 December 2020

1 reference

12 December 2020

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

10.2165/00002512-199202020-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference